<DOC>
	<DOCNO>NCT01495039</DOCNO>
	<brief_summary>Purpose . Oral chemoprophylaxis advocate reduce incidence Candida colonization infection . However , Candida prophylaxis intensive care unit ( ICU ) still matter debate . Methods . Randomized , single-center trial study single drug ( nystatin ) versus control surgical ICU patient . Multiple-site test fungi perform patient ICU admission ( T0 ) subsequently every 3 day ( T3 , T6 , T9… ) . The primary evaluation criterion time course colonization index ( CI ) ICU stay .</brief_summary>
	<brief_title>Antifungal Prophylaxis Intensive Care Unit ( ICU ) Patients</brief_title>
	<detailed_description>Multiple-site test fungi include : tracheal secretion , pharingael swab , stomach content , rectal swab , groin skin fold swab , urine , blood . These test perform patient ICU admission ( T0 ) subsequently every 3 day throughout ICU stay ( T3 , T6 , T9… ) , routine ICU.The specimen place dry medium take Mycology Laboratory . Group assignment indicate specimen , mycologist therefore blind treatment allocation . Each specimen directly microscopically examine culture Sabouraud medium .</detailed_description>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Nystatin</mesh_term>
	<criteria>surgical patient admit ICU old 18 year age expect require invasive mechanical ventilation 48 h. pregnancy , proven Candida infection , prophylactic curative antifungal treatment within last 2 month , contraindication oral drug administration , know allergy nystatin derivative , prior inclusion study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>